Specific immunotherapy : clinical experience with recombinant molecular major allergens and hypoallergenic variants
Currently, preparations containing native allergens or allergoids are used predominantly in allergen-specific immunotherapy (SIT) of inhaled allergies. The safety and efficacy of these preparations has been demonstrated. However, their reproducible production and standardisation requires substantial...
Gespeichert in:
Veröffentlicht in: | HNO 2013-10, Vol.61 (10), p.834-842 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | ger |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!